Search

Your search keyword '"Sanchez-Perez, Luis A."' showing total 291 results

Search Constraints

Start Over You searched for: Author "Sanchez-Perez, Luis A." Remove constraint Author: "Sanchez-Perez, Luis A."
291 results on '"Sanchez-Perez, Luis A."'

Search Results

8. Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

11. Supplementary Figure 7 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

12. Supplementary Data from Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

13. Data from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

14. Table S2 from A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

15. Table S2 from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

16. Supplementary Figure 5 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

17. Supplementary Figure 4 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

18. Supplementary Figure 1 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

19. Figure S1 from A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

20. Supplementary Figure 2 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

21. Figure S2 from Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

22. Supplementary Figure 6 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

23. Supplementary Table 1 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

24. Supplementary Figure 3 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

25. Data from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

26. Supplementary Figure 4 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

27. Supplementary Figure 3 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

28. Supplementary Figure 5 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

29. Supplementary Figure 1 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

30. Supplementary Figure 2 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

31. Supplementary Figure 6 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

32. Supplementary Figure 7 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

36. Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models

42. A Modification of the Lernmatrix for Real Valued Data Processing

44. Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma.

48. Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

50. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

Catalog

Books, media, physical & digital resources